Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Health & MedicineOne-Off1aManifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoPrevisione della comunità attualeNo 77.9%
Previsori
14
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato 12 ore fa
Obsoleto21 feb 23, 20:23 UTC31 dic 27, 22:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRegole
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Mercati aperti
Health & Medicine
POLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Volume totale
- 650,1K €
- Volume 24h
- 29,7K €
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 20,5K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 5,2K €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Volume totale
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Volume totale
- 915,1K €
- Volume 24h
- 3,2K €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before 2027+8.0pt84%
- before April 202781%
- before December+1.0pt69%
+3 altri esiti
- Volume totale
- 14,2K €
- Measles cases in 2026?
- New pandemic before 2028?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Which countries will have an Ebola case in 2026?
Domande frequenti
- Quali sono le probabilità attuali per Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- Manifold Markets quota No al 78% al 8 settembre 2026.
- Quando si risolve Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? dovrebbe risolversi il 31 dicembre 2027.
- Come viene liquidato Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- Manifold Markets liquida questo mercato come segue: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.